What Are The Best Biohacks?

Ice baths and breathwork dominate the conversation. The peer-reviewed literature tells a quieter story. A ranking of the ten lifestyle and behavioral interventions with the deepest evidence base, with every hazard ratio traced to a primary source, and an honest accounting of what did not make the cut.

Search the word biohacking and you will find ice baths, red light panels, grounding mats, and breathing protocols named after Dutch extreme athletes. Search the peer-reviewed literature for the same term and you find something quieter and far less photogenic: cardiorespiratory fitness, muscular strength, sleep regularity, and the company you keep.

This ranking is built on a single question. Which lifestyle and behavioral interventions have the deepest, broadest, and most replicated evidence base across general health outcomes, meaning all-cause mortality, cardiovascular disease, metabolic health, cognition, and mental health? Not which produces the largest effect on one narrow surrogate marker. Not which is most discussed. Which is best evidenced.

The ordering weights evidence quality and quantity, not raw effect size. That is why sauna, which shows some of the most dramatic hazard ratios on this entire list, ranks ninth: those numbers come from essentially one observational cohort of Finnish men. It is also why supplements, nootropics, and pharmaceuticals are absent entirely. This list is behavior only.

Every number below is traceable to a primary source. Where a widely repeated claim outruns its evidence, that is stated plainly rather than smoothed over.

1. Cardiorespiratory Fitness and Aerobic Exercise

What the evidence supports: 150 to 300 minutes per week of moderate aerobic activity, or 75 to 150 minutes of vigorous activity, with mortality benefit continuing well beyond that minimum. In practice: a base of low-intensity aerobic volume plus at least one weekly high-intensity effort.

This is the most defensible mortality intervention available to a human being, and it is not close. In a retrospective cohort of 122,007 patients undergoing treadmill testing (mean age 53.4 years, 59 percent men, mean follow-up 8.4 years), Mandsager and colleagues found that participants in the lowest fitness category carried an adjusted all-cause mortality hazard ratio of 5.04 (95 percent CI 4.10 to 6.20) compared with elite performers. The authors noted this risk was comparable to or greater than traditional clinical risk factors including coronary artery disease, diabetes, and smoking. Critically, they observed no upper limit of benefit. Fitter was always better.

The dose-response has been mapped in detail. Arem and colleagues pooled six cohorts totalling roughly 661,000 adults and found mortality hazard ratios of 0.80 for those doing less than the recommended minimum, 0.69 at one to two times the minimum, and a plateau near 0.61 at three to five times the minimum. There was no evidence of harm at ten times the recommended dose (HR 0.69, 95 percent CI 0.59 to 0.78). The J-curve so often invoked to warn against excessive endurance training does not appear in the mortality data at these volumes.

The honest caveat: you cannot randomize forty years of fitness. The fitness-mortality relationship is observational, and reverse causation is a real concern because subclinical disease lowers fitness before it kills. Statistical adjustment mitigates this but does not eliminate it. Randomized exercise trials exist in abundance, but they report intermediate endpoints, not multi-decade mortality.

2. Resistance Training

What the evidence supports: roughly 30 to 60 minutes per week of muscle-strengthening activity, which is the mortality sweet spot, independent of aerobic exercise. Train more than that for hypertrophy and strength. Just be aware that the mortality curve flattens.

Momma and colleagues meta-analyzed 16 prospective cohorts and found that muscle-strengthening activity was associated with a 10 to 17 percent lower risk of all-cause mortality, cardiovascular disease, total cancer, and diabetes. The dose-response was J-shaped, with maximal risk reduction of roughly 10 to 20 percent at 30 to 60 minutes per week and no clear additional benefit, and possible attenuation, beyond about 60 minutes per week. The authors rated overall evidence quality as low to very low for several outcomes, which is worth holding onto.

Muscular strength also functions as a prognostic biomarker. In the PURE study, Leong and colleagues followed 139,691 participants across 17 countries and found that each 5 kilogram reduction in grip strength was associated with an all-cause mortality hazard ratio of 1.16 (95 percent CI 1.13 to 1.20) and a cardiovascular mortality hazard ratio of 1.17 (95 percent CI 1.11 to 1.24). Grip strength outperformed systolic blood pressure as a mortality predictor.

The honest caveat: grip strength is a marker of systemic muscular fitness. Nothing in the PURE data suggests that training your grip specifically lowers your mortality. Squeezing a hand dynamometer is not the intervention. Being the kind of person who is strong is.

3. Smoking Cessation

It is a behavior, it is modifiable, and for anyone who smokes or vapes nicotine it dominates every other item on this list by a wide margin.

Jha and colleagues followed approximately 216,000 US adults and found that current smokers carried roughly three times the all-cause mortality of never-smokers (hazard ratio 3.0 in women, 2.8 in men). Quitting at around age 39 reduced the excess risk of death by approximately 90 percent, though a residual excess of roughly 20 percent remained.

A 2024 analysis of approximately 1.5 million adults across four countries by Cho and colleagues quantified the payoff more concretely. Quitting before age 40 was associated with roughly 12 additional years of survival to age 80. Quitting between 40 and 49 bought about 6 years, and between 50 and 59, about 2.5 years. Benefits began to emerge within three years of quitting.

The honest caveat: this is observational, because no ethics board will randomize people to keep smoking. But the consistency, dose-response, and mechanistic plausibility make the causal case as settled as anything in epidemiology. It is also a removal of harm rather than an additive optimization, which is why it rarely appears on biohacking lists at all. That is a failure of framing, not of evidence.

4. Sleep Duration and, More Importantly, Sleep Regularity

What the evidence supports: approximately 7 hours per night, and highly consistent sleep and wake times from day to day.

The duration story is a U-shaped curve, and it is well replicated. Cappuccio and colleagues established the shape in a 2010 meta-analysis: both short and long sleep predict mortality. Yin and colleagues later quantified the dose-response, finding a relative risk of 1.06 (95 percent CI 1.04 to 1.07) per hour below 7 hours and 1.13 (95 percent CI 1.11 to 1.15) per hour above 7 hours. The nadir sits at roughly seven hours.

The regularity story is newer and, for most people, more actionable. Windred and colleagues analyzed 60,977 UK Biobank participants with more than 10 million hours of accelerometry data over a mean 6.3 years of follow-up. Compared with the least regular quintile, more regular sleepers showed 20 to 48 percent lower all-cause mortality, 16 to 39 percent lower cancer mortality, and 22 to 57 percent lower cardiometabolic mortality. Sleep regularity was a stronger predictor of mortality than sleep duration.

In plain terms: going to bed and waking at the same time every day appears to matter more than the total on the clock. A parallel UK Biobank analysis found a hazard ratio of 1.53 (95 percent CI 1.41 to 1.66) comparing the 5th percentile of sleep regularity against the median.

The honest caveat: observational, with obvious reverse causation risk given that illness disrupts sleep. The regularity finding, striking as it is, rests on a single cohort using a novel metric with relatively short follow-up. It deserves attention, not certainty.

5. A Mediterranean Dietary Pattern

Of every dietary pattern marketed to the optimization crowd, exactly one has a large primary-prevention randomized controlled trial with hard cardiovascular endpoints behind it. It is not carnivore, it is not keto, and it is not any of the protocols currently trending.

In PREDIMED, Estruch and colleagues randomized 7,447 adults at high cardiovascular risk and followed them for approximately 4.8 years. A Mediterranean diet supplemented with extra-virgin olive oil produced a hazard ratio of 0.70 (95 percent CI 0.54 to 0.92) for major cardiovascular events, meaning myocardial infarction, stroke, or cardiovascular death. The version supplemented with mixed nuts produced a hazard ratio of 0.72 (95 percent CI 0.54 to 0.96). That is roughly a 30 percent relative risk reduction on hard outcomes, not on a surrogate marker.

The honest caveat, and it is a significant one: the original 2013 PREDIMED paper was retracted over randomization irregularities, including household-level and site-level assignment in some clinics. It was reanalyzed and republished in 2018, and the primary conclusions held. The population was Spanish and at high cardiovascular risk, which limits generalizability. Diet trials cannot be blinded and depend on self-report. All of that is true, and PREDIMED still has better evidence than every competing dietary pattern.

6. Daily Steps and Reducing Sedentary Time

What the evidence supports: approximately 7,000 to 8,000 steps per day, and breaking up long sedentary bouts.

The Steps for Health Collaborative meta-analyzed 15 international cohorts covering roughly 47,000 adults. Mortality declined progressively with more steps, but the benefit plateaued at around 6,000 to 8,000 steps per day in adults aged 60 and older, and around 8,000 to 10,000 steps in adults under 60. The 10,000 step target is a legacy of Japanese pedometer marketing, not a threshold derived from data.

On sitting, Ekelund and colleagues performed a harmonized meta-analysis of more than one million people. High sitting time raised mortality, but approximately 60 to 75 minutes per day of moderate activity eliminated the excess risk associated with sitting eight or more hours daily. In the least active, activity attenuated the risk without erasing it.

The honest caveat: observational, skewed toward older cohorts, and vulnerable to reverse causation because sick people move less. Steps and cardiorespiratory fitness also measure overlapping constructs, so the benefits here are not simply additive with those in section one.

7. Social Connection

This is the item most likely to be skipped by the audience that most needs it.

Holt-Lunstad and colleagues meta-analyzed 148 studies covering 308,849 people with an average 7.5 years of follow-up. Stronger social relationships were associated with an odds ratio of 1.50 (95 percent CI 1.42 to 1.59), meaning a roughly 50 percent greater likelihood of survival. The effect was comparable to smoking cessation and exceeded obesity and physical inactivity as a mortality risk factor. Complex measures of social integration performed strongest, with an odds ratio of 1.91 (95 percent CI 1.63 to 2.23).

The honest caveat: observational, with heterogeneous definitions of connection and clear reverse causation risk, since illness reduces social contact. There will never be a randomized trial with a mortality endpoint here. But the effect size sits in the same tier as diet and daily movement, and it deserves to be treated as a health behavior rather than a soft variable.

8. Circadian Light Management

What the evidence supports: bright light during the day, darkness at night, and consistency in the pattern.

Windred, Burns, and colleagues analyzed personal light exposure in 88,905 UK Biobank participants using roughly 13 million hours of light data over approximately 8 years of follow-up, capturing 3,750 deaths. Those in the brightest night-light exposure band (90th to 100th percentile) showed adjusted all-cause mortality hazard ratios of 1.21 to 1.34 relative to the darkest group. Those with the brightest daytime light exposure showed adjusted hazard ratios as low as 0.66 to 0.83. Lower circadian amplitude and shifted circadian phase also predicted higher mortality, with the strongest signal in cardiometabolic death.

The honest caveat: the sensors captured light intensity, not light source. Bright light at night plausibly proxies for shift work, poor sleep hygiene, and a cluster of confounded lifestyle factors rather than acting as an independent toxin. The mechanistic case for circadian entrainment is strong, but the mortality evidence here is associative. Morning bright light therapy has randomized support mostly for mood and circadian rhythm disorders, not for longevity.

9. Sauna and Heat Exposure

What the observational data supports: 4 to 7 sessions per week, sessions longer than 19 minutes, in a traditional Finnish sauna at roughly 80 to 100 degrees Celsius.

In the Kuopio Ischaemic Heart Disease Risk Factor Study, Laukkanen and colleagues followed 2,315 middle-aged Finnish men for a median of 20.7 years. Compared with one session per week, 4 to 7 sessions per week was associated with a sudden cardiac death hazard ratio of 0.37 (95 percent CI 0.18 to 0.75), with parallel inverse trends for fatal coronary heart disease, fatal cardiovascular disease, and all-cause mortality. Sessions longer than 19 minutes, compared with under 11 minutes, produced a sudden cardiac death hazard ratio of 0.48 (95 percent CI 0.31 to 0.75). A later extension to 1,688 men and women found cardiovascular mortality declining roughly linearly with sauna frequency.

The honest caveat, and it is the reason sauna sits at ninth rather than second: this is essentially one observational cohort, originally men only, in a culture where sauna use is normalized. There is no randomized trial with hard endpoints. The confounding potential is severe. Frequent sauna use plausibly marks higher socioeconomic status, more leisure time, better baseline health, and post-exercise habit. Those hazard ratios are almost certainly inflated by healthy-user bias. The popular framing of sauna as proven longevity medicine runs well ahead of what a single Finnish cohort can establish.

10. Meditation and Mindfulness

Goyal and colleagues conducted the systematic review that should have recalibrated this field and largely did not. Across 47 trials and 3,515 participants, mindfulness meditation programs produced small effects, with effect sizes around 0.3, on anxiety, depression, and pain at eight weeks, with continued but smaller effects at three to six months.

Two findings from that review deserve to be quoted more often than they are. First, there was no good evidence that meditation outperformed active controls such as exercise, medication, or other therapies. Second, there was no evidence of benefit beyond nonspecific controls for positive mood, attention, substance use, sleep, or weight.

The honest caveat: meditation cannot be blinded, so expectancy effects are baked in, and publication bias is likely. The effects are real. They are also small, largely psychological, and better supported for stress and anxiety than for any physical health outcome. It earns tenth place, not exclusion, and not the transformational billing it usually receives.

What Did Not Make the List, and Why

Cold plunges and cold-water immersion. A 2025 systematic review and meta-analysis by Cain and colleagues found only around 11 randomized controlled trials, most involving a single immersion, with only one including women. It found no clinically meaningful, durable effects on inflammation or health, and explicitly flagged the disconnect between popularity and evidence. There are no randomized trials with hard endpoints. More pointedly for anyone training for muscle: post-exercise cold immersion blunts hypertrophy. Roberts and colleagues showed that 10 minutes at approximately 10 degrees Celsius after resistance training attenuated satellite cell activity, anabolic p70S6K signalling, and long-term gains in muscle fibre size and strength compared with active recovery. Subsequent work by Fyfe and colleagues and a 2024 meta-analysis corroborated it. Cold may still help acute soreness and mood. That is a much narrower claim than the one being sold.

Intermittent fasting and time-restricted eating. The benefits track caloric restriction, not meal timing. In the TREAT randomized trial, Lowe and colleagues found that 16:8 time-restricted eating produced a between-group weight difference of only 0.26 kilograms versus control (95 percent CI negative 1.30 to 0.78, p equals 0.63, not significant). In the DXA subcohort, of the roughly 1.70 kilograms lost, approximately 1.10 kilograms, or about 65 percent, was lean mass. That is far above the typical 20 to 30 percent, and the authors cautioned that time-restricted eating could exacerbate muscle loss. Meal timing is not the mechanism. Eating less is.

Standalone breathwork. Fincham and colleagues meta-analyzed randomized trials and found small effects on stress (Hedges g of negative 0.35, 95 percent CI negative 0.55 to negative 0.14), anxiety, and depression. Three of the stress trials carried high risk of bias and the remainder had some concerns. The authors themselves urged caution to avoid a miscalibration between hype and evidence. Reasonable for acute stress. Unsupported for the broader physical and performance claims attached to it.

Grounding and earthing. No credible large-scale or well-controlled evidence. Small studies, surrogate outcomes, and frequent commercial entanglement.

Blue-light-blocking glasses. Weak and mixed evidence for meaningful sleep or health outcomes. Any real circadian benefit is better achieved by fixing the intensity and timing of light exposure than by tinting a lens.

Wearable-driven HRV optimization. Heart rate variability is a legitimate biomarker of autonomic state. There is no randomized evidence that chasing a daily HRV score on a consumer device improves any hard health outcome, and the practice carries real risk of over-optimization and sleep-tracking anxiety.

Where to Actually Start

The evidence sorts itself into tiers, and the tiers should dictate the order of operations.

Build the foundation first. These carry the highest return and the hardest evidence.

  1. Train cardiorespiratory fitness: 150 to 300 minutes per week of moderate aerobic work, or 75 to 150 minutes vigorous, with at least one weekly high-intensity effort.

  2. Resistance train two to three times per week. Roughly 30 to 60 minutes weekly is the mortality sweet spot. Train more for physique and strength goals.

  3. If you smoke or vape nicotine, quit. For those to whom it applies, this outranks everything else on this page.

  4. Anchor sleep at approximately 7 hours, and prioritize regularity over duration.

Then layer in.

  1. Adopt a Mediterranean-style dietary pattern built on extra-virgin olive oil, nuts, legumes, fish, vegetables, and whole grains.

  2. Target roughly 7,000 to 8,000 steps per day and break up prolonged sitting.

  3. Invest deliberately in social connection. The data place it alongside diet and movement, not below them.

  4. Manage circadian light: bright early and during the day, dim and dark at night.

Optional adjuncts, only if they do not crowd out the above.

  1. Sauna, if accessible and enjoyable. Aim for the pattern in the Finnish data: four or more sessions weekly, 15 to 20 minutes each. Plausibly beneficial. Unproven.

  2. Meditation for stress and mood, with realistic expectations. Structured eight-week programmes have the best data.

One structural warning. Do not sum the risk reductions on this page. Several items measure overlapping constructs. Cardiorespiratory fitness, daily steps, and sedentary time are correlated. Sleep duration and sleep regularity overlap. The effects are not additive, and treating them as though they are will produce a wildly optimistic personal model.

A second warning, more important. Almost all mortality evidence for lifestyle factors is observational. Healthy-user bias and reverse causation inflate these associations, and the exercise and Mediterranean-diet literatures are the main places where randomized evidence exists at all. Where a single cohort dominates an intervention's evidence base, as with Kuopio for sauna and UK Biobank for sleep regularity and light, that concentration is itself a limitation.

What would change this ranking? A well-powered randomized trial of sauna or cold exposure with hard endpoints. A time-restricted eating trial that isolates meal timing from caloric intake and still shows independent benefit. Mendelian randomization or trial evidence upgrading light exposure or social connection from association to causation. Absent those, the top four are not moving.

This article is a general-health brief for healthy adults and is not medical advice. Sauna, cold exposure, and vigorous exercise carry individual cardiovascular cautions. Anyone with existing cardiac, blood-pressure, or metabolic disease should consult a clinician before adopting intensive heat, cold, or high-intensity protocols.

References

  1. Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Network Open. 2018;1(6):e183605. doi:10.1001/jamanetworkopen.2018.3605

  2. Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Internal Medicine. 2015;175(6):959-967. doi:10.1001/jamainternmed.2015.0533

  3. Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. British Journal of Sports Medicine. 2022;56(13):755-763. doi:10.1136/bjsports-2021-105061. PMID 35228201

  4. Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet. 2015;386(9990):266-273. doi:10.1016/S0140-6736(14)62000-6

  5. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. New England Journal of Medicine. 2013;368:341-350. doi:10.1056/NEJMsa1211128

  6. Cho ER, Brill IK, Gram IT, Brown PE, Jha P. Smoking cessation and short- and longer-term mortality. NEJM Evidence. 2024. doi:10.1056/EVIDoa2300272

  7. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585-592. doi:10.1093/sleep/33.5.585. PMID 20469800

  8. Yin J, Jin X, Shan Z, et al. Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective cohort studies. Journal of the American Heart Association. 2017;6(9):e005947. doi:10.1161/JAHA.117.005947

  9. Windred DP, Burns AC, Lane JM, Saxena R, Rutter MK, Cain SW, Phillips AJK. Sleep regularity is a stronger predictor of mortality risk than sleep duration: a prospective cohort study. Sleep. 2024;47(1):zsad253. doi:10.1093/sleep/zsad253. PMID 37738616

  10. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine. 2018;378:e34. doi:10.1056/NEJMoa1800389

  11. Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet Public Health. 2022;7(3):e219-e228. doi:10.1016/S2468-2667(21)00302-9. PMID 35247352

  12. Ekelund U, Steene-Johannessen J, Brown WJ, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. The Lancet. 2016;388(10051):1302-1310. doi:10.1016/S0140-6736(16)30370-1

  13. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Medicine. 2010;7(7):e1000316. doi:10.1371/journal.pmed.1000316

  14. Windred DP, Burns AC, Lane JM, Olivier P, Rutter MK, Saxena R, Phillips AJK, Cain SW. Brighter nights and darker days predict higher mortality risk: a prospective analysis of personal light exposure in more than 88,000 individuals. PNAS. 2024;121(43):e2405924121. doi:10.1073/pnas.2405924121

  15. Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Internal Medicine. 2015;175(4):542-548. doi:10.1001/jamainternmed.2014.8187. PMID 25705824

  16. Laukkanen T, Kunutsor SK, Khan H, Willeit P, Zaccardi F, Laukkanen JA. Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study. BMC Medicine. 2018;16:219. doi:10.1186/s12916-018-1198-0. PMID 30486813

  17. Goyal M, Singh S, Sibinga EMS, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine. 2014;174(3):357-368. doi:10.1001/jamainternmed.2013.13018. PMID 24395196

  18. Cain T, Brinsley J, Bennett H, Nelson M, Maher C, Singh B. Effects of cold-water immersion on health and wellbeing: a systematic review and meta-analysis. PLoS One. 2025;20(1):e0317615. doi:10.1371/journal.pone.0317615

  19. Roberts LA, Raastad T, Markworth JF, et al. Post-exercise cold water immersion attenuates acute anabolic signalling and long-term adaptations in muscle to strength training. The Journal of Physiology. 2015;593(18):4285-4301. doi:10.1113/JP270570

  20. Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Internal Medicine. 2020;180(11):1491-1499. doi:10.1001/jamainternmed.2020.4153

  21. Fincham GW, Strauss C, Montero-Marin J, Cavanagh K. Effect of breathwork on stress and mental health: a meta-analysis of randomised-controlled trials. Scientific Reports. 2023;13:432. doi:10.1038/s41598-022-27247-y. PMID 36624160